NIH-funded research NIH-funded research

How certain DNA elements affect aging and Alzheimer's disease

Official title: The Role of Transposable Elements in Healthy Aging and in Alzheimer's Disease

Funded at Feinstein Institute for Medical Research · NIH-11321491 · Data updated 2026-11-12

This study is looking at how certain genetic elements in our DNA might affect healthy aging and Alzheimer's disease by examining brain cells and signals in mice, which could help us understand more about these conditions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionFeinstein Institute for Medical Research
NIH-funded
Lab location1 site (Manhasset, United States)
Project startSeptember 15, 2022
Project endAugust 31, 2025
Funding year2022
Award (this year)$345,514
NIH project number7R56AG078970-02
Project IDNIH-11321491 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include older adults and individuals at risk for Alzheimer's disease.

Less likely to help

Patients with early-stage Alzheimer's disease or those with other unrelated neurological conditions may not benefit directly from this research.

What this research studies

This research investigates the role of transposable elements, particularly human endogenous retroviruses, in the processes of healthy aging and Alzheimer's disease. By analyzing RNA sequencing data, the study aims to identify patterns of gene expression related to these elements in different brain regions and cell types. The researchers are also exploring the impact of specific signaling pathways on neurodegeneration using a mouse model. This approach could provide insights into the molecular mechanisms underlying aging and Alzheimer's disease.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for preventing or treating Alzheimer's disease and improving healthy aging.

How similar studies have gone: While the role of transposable elements in disease is an emerging field, preliminary studies have shown promising results in understanding their impact on neurodegeneration.

Where this research is happening

  • Feinstein Institute for Medical Research
    Manhasset, United States
    Active

Researchers

  • Principal investigator: Nixon, Douglas F — Feinstein Institute for Medical Research
  • Study coordinator: Nixon, Douglas F

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.